History Says VUG Is Not Worth Your Money. Hold This Instead

Photo of Omor Ibne Ehsan
By Omor Ibne Ehsan Published

Quick Read

  • QQQ’s tighter Nasdaq-100 roster captures more upside from megacap winners than VUG’s sprawling CRSP index, making index methodology the real performance differentiator beyond fees.

  • The analyst who called NVIDIA in 2010 just named his top 10 AI stocks. Get them here FREE.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
History Says VUG Is Not Worth Your Money. Hold This Instead

© 24/7 Wall St.

Over the past decade, Vanguard Growth ETF (NYSEARCA:VUG | VUG Price Prediction) returned 427% while Invesco QQQ Trust (NASDAQ:QQQ) delivered 563%. VUG’s broader CRSP index dilutes winners. QQQ concentrates them, and downturns barely separated the two. Over five years, VUG gained 98% against QQQ’s 113%. At 0.18%, QQQ’s expense ratio and concentration profile explain the performance gap.

Why index construction is destiny

VUG tracks the CRSP US Large Cap Growth Index, a sprawling benchmark that pulls in hundreds of names the moment they cross a growth-factor threshold. That breadth sounds prudent, but in practice it means the fund holds a long tail of mid-tier growth stocks that drag on returns when megacap leadership runs hot. QQQ, by contrast, tracks the Nasdaq-100, a tighter roster of the largest non-financial companies listed on the Nasdaq exchange. When the market’s biggest winners have been Nasdaq-listed mega-cap technology names, QQQ’s construction quietly captures more of that upside while VUG’s CRSP methodology spreads the bet.

Investors who confuse “growth” with “growth-y” pay a price for that distinction. VUG is a perfectly reasonable diversified growth product, but diversification within an already-narrow factor sleeve is a recipe for mediocrity. If you already own a broad-market fund, and most investors dom then layering VUG on top is closet indexing. QQQ at least gives you something different: real concentration in the names actually driving earnings growth.

Concentration risk cuts both ways

QQQ is heavily weighted toward a handful of mega-cap technology stocks, and a sustained rotation away from that group would hurt. The top ten holdings in QQQ regularly account for more than half of the fund’s assets, and Apple, Microsoft, Nvidia, Amazon, and Alphabet collectively dominate the index. If artificial-intelligence enthusiasm cools, if antitrust regulators clip the wings of platform companies, or if interest rates climb back to multi-decade highs, QQQ would feel the pain first and feel it most.

But concentration is not inherently a flaw. It is a feature with a known cost. The investor’s job is to decide whether that cost is acceptable given the offsetting benefit. Namely, owning more of what actually compounds. Over the past decade, the answer has clearly been yes. QQQ’s outperformance has not been a fluke or a single-year anomaly; it has been the steady result of owning the right names in the right weights.

The fee story is overrated

VUG bulls often point to the expense ratio as a tiebreaker. Vanguard’s growth ETF charges a rock-bottom fee, while QQQ is meaningfully more expensive in basis-point terms. On paper, that gap compounds over decades. In practice, it has been completely swamped by the performance differential. A few extra basis points in fees mean nothing if the underlying portfolio is leaving multiple percentage points of annual return on the table. Investors fixate on fees because they are visible and quantifiable, while index construction differences are harder to see. But the latter has mattered far more.

For fee-sensitive investors who still want Nasdaq-100 exposure, Invesco offers QQQM, a lower-cost share class of the same underlying strategy. That product effectively neutralizes the fee argument entirely while preserving the index advantage.

What to do now

None of this is a guarantee that QQQ will keep beating VUG over the next decade. Markets rotate, leadership changes, and concentrated funds can underperform for long stretches when their favored sector falls out of favor. But the historical record is unambiguous, the structural reasons behind it are sound, and the alternative, holding VUG as a primary growth allocation, looks more like habit than analysis.

If you already own VUG and have meaningful unrealized gains, the tax bill of switching may not be worth it. But for new money, or for tax-advantaged accounts where the swap is costless, the case for QQQ (or QQQM) over VUG remains compelling. History says so, and so does the math of index construction. Until something fundamental changes about which companies are driving American earnings growth, the concentrated bet has been, and likely will continue to be, the better one.

 

Photo of Omor Ibne Ehsan
About the Author Omor Ibne Ehsan →

Omor Ibne Ehsan is a writer at 24/7 Wall St. He is a self-taught investor with a focus on growth and cyclical stocks that have strong fundamentals, value, and long-term potential. He also has an interest in high-risk, high-reward investments such as cryptocurrencies and penny stocks.

Continue Reading

Top Gaining Stocks

D Vol: 15,051,964
NOW Vol: 22,110,983
FDS Vol: 182,286
CTSH Vol: 3,724,170
TTD Vol: 7,142,623

Top Losing Stocks

REGN Vol: 1,437,181
CTRA Vol: 73,319,495
STX Vol: 1,683,255
GLW Vol: 5,871,574
ENPH Vol: 4,232,648